Literature DB >> 13841011

Studies of the effect of a colloidal radioactive chromic phosphate (Cr32PO4) in clincal and experimental malignant effusions.

H A VAN DEN BRENK, K H CLARKE, W P HOLMAN, C WINKLER.   

Abstract

Entities:  

Keywords:  CHROMIUM/radioactive; NEOPLASMS/radiotherapy; PHOSPHORUS/radioactive

Mesh:

Substances:

Year:  1959        PMID: 13841011      PMCID: PMC2074040          DOI: 10.1038/bjc.1959.25

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  The effect of oral administration of hydrogen peroxide on neoplastic growth; experimental screening studies.

Authors:  H A VAN DEN BRENK
Journal:  Med J Aust       Date:  1958-05-10       Impact factor: 7.738

2.  A comparison of methods for estimating the viable count of a suspension of tumour cells.

Authors:  J M HOSKINS; G G MEYNELL; F K SANDERS
Journal:  Exp Cell Res       Date:  1956-08       Impact factor: 3.905

3.  Treatment of malignant serous effusions with radioactive colloidal chromic phosphate.

Authors:  H L JAFFE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1955-10

4.  Quantitative studies of ascitic fluid circulation with tritium-labeled water.

Authors:  T C PRENTICE; W SIRI; E E JOINER
Journal:  Am J Med       Date:  1952-12       Impact factor: 4.965

5.  Distribution of colloidal radioactive chromic phosphate after intracavitary administration.

Authors:  S W ROOT; M P TYOR; G A ANDREWS; R M KNISELEY
Journal:  Radiology       Date:  1954-08       Impact factor: 11.105

6.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  6 in total
  1 in total

Review 1.  Evolution of radiation protection for medical workers.

Authors:  John Boice; Lawrence T Dauer; Kenneth R Kase; Fred A Mettler; Richard J Vetter
Journal:  Br J Radiol       Date:  2020-06-04       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.